Park Medi World Ltd, the second-largest private hospital chain in North India, submitted its DRHP to SEBI with the plan to raise ₹1,260 crore through an IPO.
This public issue comprises a mixture of both a fresh issue of ₹960 crore and an offer-for-sale of up to ₹300 crore by the promoter.
The company may raise funds of ₹192 crore through pre-IPO placement. If they successfully plan to launch funds through a pre-IPO round, then the amount of ₹192 crore will be deducted from the fresh issue amount.
As of December 2024, the company’s debt remained at ₹593.6 crore. The proceeds of ₹410 crore will be utilized for the repayment of old debts taken by the company.
Moreover, the funds of ₹110 crore will be utilized for the establishment of a new hospital and the growth of the existing hospital. The funds of ₹77.2 crore will be used to buy the medical equipment. Whereas, the remaining funds will be utilized for the company’s general purposes.
Established in 1982, Park Medi World Ltd is one of the largest private hospitals in India, with a total of 3,000 beds. Under the Park brand, they operate 13 multi-super specialty hospitals, of which 8 hospitals are located in Haryana, 1 in New Delhi, 2 in Punjab, and 2 in Rajasthan.
The book-running lead managers of this public issue are Nuvama Wealth Management, CLSA India, DAM Capital Advisors, and Intensive Fiscal Services.
In FY24, the company generated a revenue of ₹12,310.66 million from operations, and the company also resulted in a 45.84% profit after tax.
Park Medi World IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | To be Updated Soon |
Park Medi World Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax |
| 2022 | ₹1,093.96 | ₹815.59 | ₹199.38 |
| 2023 | ₹1,272.18 | ₹955.37 | ₹228.19 |
| 2024 | ₹1,263.08 | ₹1,041.66 | ₹152.01 |
| September 2024 | ₹707.45 | ₹559.95 | ₹112.89 |
Park Medi World IPO Valuation – FY2024
Park Medi World IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹3.95 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 18.81% |
| Net Asset Value (NAV): | ₹21.23 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Apollo Hospitals Enterprise Limited | 62.50 | 99.46 | 12.98% | 481.60 | 19,165.5 Cr. |
| Fortis Healthcare Limited | 7.93 | 79.38 | 7.82% | 101.50 | 6,931.2 Cr. |
| Narayana Hrudalaya Limited | 38.86 | 40.30 | 27.39% | 141.03 | 5,093.4 Cr. |
| Max Healthcare Institute Limited | 10.89 | 90.53 | 12.58% | 86.51 | 5,584.1 Cr. |
| Krishna Institute of Medical Sciences Limited | 7.75 | 66.14 | 16.96% | 45.69 | 2,511.2 Cr. |
| Global Health Limited | 17.80 | 68.90 | 16.53% | 107.77 | 3,349.8 Cr. |
| Jupiter Lifeline Hospitals Ltd | 28.65 | 52.10 | 15.11% | 178.30 | 1,095.5 Cr. |
| Yatharth Hospital & Trauma Care Services Limited | 14.46 | 27.01 | 13.09% | 101.84 | 686.2 Cr. |
Objects of the Issue
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company and certain of our Subsidiaries;
- Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively;
- Funding capital expenditure for purchase of medical equipment by our Company and our certain Subsidiaries, Blue Heavens and Ratangiri; and
- Unidentified inorganic acquisitions and general corporate purposes.
IPO Lead Managers aka Merchant Bankers
- Nuvama Wealth Management Limited
- CLSA India Private Limited
- DAM Capital Advisors Limited
- Intensive Fiscal Services Private Limited
